Zhang Ying, Xiao Xi-Bin, Zhang Chang-Qing, Li Jing-Lue, Sun Yun, Ye Yong-Zhao, Feng Kai-Tao
Experimental Research Department, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, PR China.
Ai Zheng. 2004 Sep;23(9):999-1004.
BACKGROUND & OBJECTIVE: Epstein-Barr virus (EBV) is closely related to nasopharyngeal carcinoma (NPC). Many kinds of methods can be used to examine antibodies in NPC patients sera. This study was to screen the dominant epitopes from random peptide libraries (RPLs) displayed on phage using the EBV-related antibodies purified from the sera of NPC patients, and find new antigens at the epitope level.
The EBV-related antibodies were eluted from the sera of NPC patients using B95-8 cell EBV proteins as antigen, and the phages from 12-mer RPLs were elutriated for 3 rounds with the antibodies. The positive clones were gained by sandwich ELISA, and competitive inhibition assay from the third elution. The positive clones were sequenced, and the peptide coded by the inserted DNA were blasted with the antigen region of EBV proteins.
Sixty-four phage clones were randomly picked up from the third eluate,25 positive clones were picked up using sandwich ELISA assay, the positive percentage was 39.06%. Thirteen clones were picked up for competitive ELISA assay,11 clones showed inhibitory phenomena,the inhibitory rates were between 18.09% and 65.94%. Five positive clones with high absorbency value, and high inhibitory rates were selected out, the sequences of peptides displayed on these clones were -A-T-S-H-L-H-V-R-L-P-W-T- (d15, and d18), -G-S-T-H-K-H-N-H-F-N-K-T- (d19), -K-P-I-H-E-H-P-H-R-F-K-S- (e8), -H-T-H-K-I-K-I-P-L-P-I-Q- (e23). These peptide sequences showed similarity with the amino acid sequences located in antigen regions of EBV integral membrane protein (d15, and d18), EBV thymidine kinase (d19), and EBV major capsid protein (e8, and e23).
EBV-related epitopes could be obtained by screening the phages from RPLs with polyclonal antibodies purified from the sera of NPC patients, which may offer new methods of antigen preparation for sera diagnosis of NPC.
爱泼斯坦-巴尔病毒(EBV)与鼻咽癌(NPC)密切相关。多种方法可用于检测NPC患者血清中的抗体。本研究旨在利用从NPC患者血清中纯化的EBV相关抗体,从噬菌体展示的随机肽库(RPL)中筛选优势表位,并在表位水平上寻找新的抗原。
以B95-8细胞EBV蛋白为抗原,从NPC患者血清中洗脱EBV相关抗体,并用该抗体对12肽RPL中的噬菌体进行3轮淘选。通过夹心ELISA和第三次洗脱后的竞争抑制试验获得阳性克隆。对阳性克隆进行测序,并将插入DNA编码的肽与EBV蛋白的抗原区域进行比对。
从第三次洗脱物中随机挑选64个噬菌体克隆,用夹心ELISA法挑选出25个阳性克隆,阳性率为39.06%。挑选13个克隆进行竞争ELISA试验,11个克隆表现出抑制现象,抑制率在18.09%至65.94%之间。筛选出5个吸光度值高、抑制率高的阳性克隆,这些克隆上展示的肽序列为-A-T-S-H-L-H-V-R-L-P-W-T-(d15和d18)、-G-S-T-H-K-H-N-H-F-N-K-T-(d19)、-K-P-I-H-E-H-P-H-R-F-K-S-(e8)、-H-T-H-K-I-K-I-P-L-P-I-Q-(e23)。这些肽序列与EBV整合膜蛋白(d15和d18)、EBV胸苷激酶(d19)和EBV主要衣壳蛋白(e8和e23)抗原区域的氨基酸序列相似。
用从NPC患者血清中纯化的多克隆抗体筛选RPL中的噬菌体可获得EBV相关表位,这可能为NPC血清诊断提供新的抗原制备方法。